Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
565-04-001.
Cluster-Specific Radiomics Predicting Induction Chemotherapy Response in Nasopharyngeal Carcinoma
Impact: This study utilizes a cluster-based radiomics which can provide clinicians with a non-invasive tool to personalize treatment, potentially improving outcomes by identifying patients who will benefit from induction chemotherapy. It enables more targeted therapy decisions.
|
||
|
565-04-002.
Improving Radiomics-Based Differentiation of Supratentorial Brain Tumors with DWI: A Three-Class Machine Learning Algorithm
Impact: Our work constructs a three-class multiparametric radiomic model for classifying supratentorial brain tumors [HGG, BM, and PCNSL], and investigate whether DWI-based radiomic features offer incremental value and improve diagnostic performance.
|
||
|
565-04-003.
Multimodal MRI-Based Habitat Model for Predicting WHO Grading and Ki-67 Labeling Index in HGG: A Multicenter Study
Impact: This work establishes a standardized habitat imaging framework for non-invasively assessing glioma heterogeneity. This approach provides valuable preoperative insights into tumor grade and proliferation, potentially informing surgical planning and personalized treatment strategies, and advancing precision neuro-oncology.
|
||
|
565-04-004.
Visual vs. Radiomics Assessment of Post-contrast T2 FLAIR - T1WI Enhancement Mismatch for IDH1 Prediction
Impact: The CE-T2 FLAIR–T1WI
enhancement mismatch enables practical, noninvasive prediction of glioma IDH1
status. A simple visual model outperforms complex radiomics, offering
clinicians a more interpretable and accessible tool, potentially guiding
surgical planning and stimulating new research in imaging biomarkers.
|
||
|
565-04-005.
A Multimodal MRI Model Integrating Radiomics and Habitat Features for Glioma Grading and Molecular Biomarker Prediction
Impact: This AI-driven tool decodes glioma complexity from standard MRIs to non-invasively predict tumor malignancy, molecular state, and patient prognosis. It provides clinicians a powerful guide for personalizing treatment, aiming to improve patient outcomes and deepen our understanding of tumor biology.
|
||
|
565-04-006.
Radiomics-Distilled Self-Supervised Deep leaning framework for Label-Efficient Glioma Treatment Response Prediction
Impact: RADIATE-Net enables clinically scalable,
label-efficient prognosis prediction, integrating expert knowledge and deep
learning. It facilitates precision oncology with limited data and opens avenues
for cross-disease, multi-modal imaging biomarker discovery.
|
||
|
565-04-007.
Radiomics-based differentiation between GBM and PCNSL: a combination of structural MRI, DCE and DTI
Impact: A radiomics model based on structural MRI, DCE and DTI was developed and demonstrated excellent performance in discriminating between GBM and PCNSL.
|
||
|
565-04-008.
Radiomics-Based Assessment of Overall Survival in Olfactory Neuroblastoma
Impact: Preoperative
MRI radiomics can provide noninvasive prognostic biomarkers for ONB, enabling
risk stratification and early identification of patients with poor survival.
This approach may guide individualized treatment and follow-up strategies in
this rare malignancy.
|
||
|
565-04-009.
A Radiomics-Based Nomogram for Predicting Complete Remission to Chemoradiotherapy in Intracranial Germ Cell Tumors
Impact: This radiomics-based nomogram provides a non-invasive tool for
predicting chemoradiotherapy response in IGCT patients. The risk stratification
strategy enables personalized treatment planning and may help reduce
unnecessary treatment-related toxicity in pediatric populations.
|
||
|
565-04-010.
Multimodal MRI Radiomics and Clinical Indicators for Predicting Short-Term Targeted Therapy Response in Locally Advanced NPC
Impact: The combined clinical-radiomics model may aid personalized treatment decisions for locally advanced nasopharyngeal carcinoma, potentially reducing ineffective therapies and improving resource use, with promising value for clinical decision support.
|
||
|
565-04-011.
Development of an Early Differential Diagnostic Model Using MRI Radiomics for Postoperative Granuloma versus Recurrent Tumor
Impact: This study developed an
early differential diagnosis model of postoperative granulomas and recurrent
tumors using MRI radiomics features and identified reliable clinical imaging
characteristics to improve the diagnostic accuracy and support postoperative
clinical decision-making.
|
||
|
565-04-012.
A Multimodal MRI Radiomics-Clinical Nomogram for Predicting IVGC Response in Graves’ Ophthalmopathy: A Multicenter Study
Impact: The proposed nomogram, which integrates multimodal MRI-based RDL features and key clinical predictors, provides a non-invasive and individualized tool for predicting IVGC treatment response in GO patients, potentially facilitating personalized treatment planning and clinical decision-making.
|
||
|
565-04-013.
Optimizing MRI Sequence Selection for Glioma Classification - Do we really need all sequences?
Impact: The study highlights the potential of reducing MRI sequences in glioma grading based on the premise that multiple sequences provide an overlap of information and thus a reduction to the most important sequences could speed up examinations.
|
||
|
565-04-014.
Comparative and Integrative Analysis of DCE-MRI, DWI-MRI, and Radiomic Features for Pre-Operative Grading of Meningiomas
Impact: The proposed methodology is a non-invasive
method that can differentiate between high-grade Meningiomas (HGMs) and low-grade Meningiomas (LGMs) and help in preoperative
grading.
|
||
|
565-04-015.
Development and validation of a multiparametric MRI–based radiomic model to distinguish benign from malignant sinonasal tumor
Impact: Multiparametric MRI radiomics, especially
combined-sequence models, accurately differentiates benign from malignant
sinonasal tumors with robust external validation, supporting improved
diagnostic decision-making.
|
||
|
565-04-016.
Differentiation between Glioblastoma and Solitary Brain Metastases: A Subregional Diagnostic Comparison
Impact: The various subregions reveal distinct heterogeneities from individual viewpoints. Combining insights from both whole tumor mass and specific local areas, they jointly depict the heterogeneous characteristics inherent to GBM and SBM. Such pathological disparities aid in distinguishing these two malignancies.
|
© 2026 International Society for Magnetic Resonance in Medicine